[Intraperitoneal infections and immunosuppression (author's transl)] NLM AIDSLINE Important note: Information in this article was accurate in 1982. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Intraperitoneal infections and immunosuppression (author's transl)]

Zentralbl Chir. 1982;107(2):65-77. Unique Identifier : AIDSLINE MED/82178441
Hau T; Lippert H

Abstract: The growing number of patients showing a restricted immune defence, also causes the surgeon to be faced with big problems; particularly in the case of intraperitoneal infections. In case of peritonitis the organism may dispose of various opportunities of immune defence involving the local limitation by adhesions, phagocyte activity, humoral and cellular immunity. Deficiencies in immune defence (congenital, acquired or iatrogenically induced) will change symptoms, diagnosis and therapy of intraperitoneal infections. Due to the lack of segmental granulocytes in patients with restricted immune defence there are frequently no symptoms of intraperitoneal infections, such as abdominal tenderness and pain. The diagnostic lavage of the abdominal cavity should be applied early. The therapy hardly differs from the general treatment of peritonitis in normal patients. The changed germ spectrum among them opportunistic germs, viruses, parasites amd mycetes, required a modified application of antibiotics. The prognosis of peritonitis in patients with restricted immune defence depends on the etiology of the infection and the degree of immunosuppression. At present a mortality rate of up to 70% is still registered.
Keywords: Antibody Formation Bacterial Infections/IMMUNOLOGY English Abstract Human Immunity, Cellular Immunologic Deficiency Syndromes/ETIOLOGY/*IMMUNOLOGY Peritonitis/*IMMUNOLOGY Prognosis Surgical Wound Infection/IMMUNOLOGY JOURNAL ARTICLE

KWDantibodyformationbacterialinfections/immunologyenglishabstracthumanimmunity,cellularimmunologicdeficiencysyndromes/etiology/KWDimmunologyperitonitis/KWDimmunologyprognosissurgicalwoundinfection/immunologyjournalarticle
820830
M8280008

Copyright © 1982 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1982. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1982. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .